ANO3 and chronic kidney disease: Variations in ANO3 could disrupt this finely tuned electrolyte balance, so the intronic ANO3 variant uncovered in our GWAS may contribute to CKD susceptibility and serve as a genetic marker for early detection of at-risk individuals.